Edwards Lifesciences Corp 8-K

What Happened
Edwards Lifesciences (EW) filed an 8‑K on February 10, 2026 (Item 2.02) furnishing a press release that reports the company’s financial results for the fourth quarter of 2025. The press release is included as Exhibit 99.1 to the filing and is incorporated by reference into the 8‑K.

Key Details

• Filing date: February 10, 2026 (Form 8‑K, Item 2.02).
• Event: Press release reporting Edwards’ Q4 2025 financial results (Exhibit 99.1).
• The 8‑K furnishes the press release but does not itself restate the detailed financials in the body of the filing.
• The submission also includes the Cover Page Interactive Data File (Inline XBRL) as Exhibit 104.

Why It Matters
This filing notifies investors that Edwards has published its quarterly earnings information for Q4 2025. Investors should review the furnished press release (Exhibit 99.1) and the company’s subsequent earnings materials for revenue, EPS, guidance, and other metrics to assess near‑term performance and any impact on valuation or guidance.